½ÃÀ庸°í¼­
»óǰÄÚµå
1618257

¼¼°èÀÇ ¾È¸é ÀÓÇöõÆ® ½ÃÀå : ÀλçÀÌÆ®, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(-2030³â)

Facial Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DelveInsight | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾È¸é ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð´Â 2023³â 25¾ï 6,000¸¸ ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È CAGR 8.02%·Î ÃßÀÌÇϰí, 2030³â¿¡´Â 40¾ï 6,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ½ÃÀåÀº Ä¡°ú ÁúȯÀ» Æ÷ÇÔÇÑ ±Þ¼º ¹× ¸¸¼º Áúȯ »ç·Ê Áõ°¡, Á¦Ç° °³¹ß Ȱµ¿ Áõ°¡, ³·Àº ħ½À óġ°¡ ¼±È£µÇ´Â °æÇâÀÌ ³ô¾ÆÁö°í, ´Ù¾çÇÑ ¾ó±¼ ÀÓÇöõÆ®ÀÇ °¡¿ë¼º¿¡ ÀÇÇØ ÇöÀúÇÑ ¼ºÀåÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù.

¾È¸é ÀÓÇöõÆ®: ½ÃÀå ¿ªÇÐ

World Health Organization(WHO)ÀÇ Global Oral Health Status Report(2022) ÃÖ±ÙÀÇ Ãß°è¿¡ µû¸£¸é, ±¸°­ ÁúȯÀº ¼¼°è¿¡¼­ ¾à 35¾ï¸íÀ» ±«·ÓÈ÷°í ÀÖÀ¸¸ç, Á߼ҵ汹°¡ 4°Ç Áß 3°ÇÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¾î¸°ÀÌ´Â À¯Ä¡ÀÇ ÃæÄ¡°¡ ÀÖ°í, ¼¼°è¿¡¼­ ÃßÁ¤ 20¾ï ¸íÀÇ ¼ºÀÎÀÌ ¿µ±¸Ä¡ÀÇ ÃæÄ¡°¡ ÀÖ´Ù°í º¸¿©ÁÝ´Ï´Ù.

¶ÇÇÑ WHO(2023) ´Â ¼¼°è Àα¸ÀÇ ¾à 19%¿¡ ÇØ´çÇÏ´Â 10¾ï ¸í ÀÌ»óÀÇ ¼ºÀÎÀÌ ½ÉÇÑ Ä¡ÁÖº´À» ¾Î°í ÀÖ´Ù°í ¸»ÇÕ´Ï´Ù. Á¦°Å ¹× Ä¡ÁÖº´ Ä¡·á¸¦ À§ÇÑ Àúħ½ÀÀ¸·Î Á¤¹ÐÇÑ Ä¡·á¸¦ Á¦°øÇϱâ À§ÇØ ·¹ÀÌÀú °³ÀÔÀÌ È¿À²ÀûÀ̰í ȯÀÚ Ä£È­ÀûÀÎ Ä¡·áÀÇ Çʿ伺ÀÌ ³ô¾ÆÁ® ¾È¸é ÀÓÇöõÆ® ½ÃÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ÅΡ¤ÇÏ¾Ç ÀÓÇöõÆ®°¡ 2023³â¿¡ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ±¸°­¾Ï¿¡¼­´Â Á¾¾çÀÌ »À¿¡ ¸Å¿ì °¡±õ°Å³ª ºÙ¾îÀÖ´Â °æ¿ì, ÇÏ¾Ç ÀýÁ¦¼úÀÌ ¼öÇàµË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ¾È¸é ÀÓÇöõÆ® ½ÃÀå¿¡¼­ Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î Ãß»êµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ½É¹ÌÀû Ä¡·á¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí, ħ½À¼ºÀÌ ³·Àº Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí, ±â¼úÀÌ Áö¼ÓÀûÀ¸·Î ¹ßÀüÇÏ´Â µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è ¾È¸é ÀÓÇöõÆ® ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ¹ý±ÔÁ¦ ȯ°æ, ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ª/ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï Á¤¼¼, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¾È¸é ÀÓÇöõÆ® ½ÃÀå º¸°í¼­ : ÀÎÆ®·Î´ö¼Ç

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ºÐ·ù
  • ½ÃÀåÀÇ »óÁ¤

Á¦2Àå ¾È¸é ÀÓÇöõÆ® ½ÃÀå : ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä

Á¦3Àå °æÀï ±¸µµ

Á¦4Àå ±ÔÁ¦ ºÐ¼®

  • ¹Ì±¹
  • À¯·´
  • ÀϺ»
  • Áß±¹

Á¦5Àå ¾È¸é ÀÓÇöõÆ® ½ÃÀå : ÁÖ¿ä ¿äÀÎ ºÐ¼®

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ±Þ¼º ¹× ¸¸¼ºÁúȯ Áõ°¡
    • Á¦Ç° °³¹ß Ȱµ¿ÀÇ È°¼ºÈ­
    • ³·Àº ħ½À ¼ö¼úÀÇ È£°¨µµ°¡ Áõ°¡
    • ´Ù¾çÇÑ À¯ÇüÀÇ ¾È¸é ÀÓÇöõÆ®°¡ ÀÌ¿ë °¡´É
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
    • ¾È¸é ÀÓÇöõÆ®¿Í °ü·ÃµÈ ÀáÀçÀû À§Çè
    • ¾È¸é Áõ°­ ¼ö¼ú¿¡ µû¸¥ °í¾×ÀÇ ºñ¿ë
  • ½ÃÀå ±âȸ
    • ·Îº¿ Áö¿ø ·¹ÀÌÀú ¼ö¼úÀÇ Àαâ
    • 3D ÇÁ¸°ÆÃ ¾È¸é ÀÓÇöõÆ® °³¹ß

Á¦6Àå ¾È¸é ÀÓÇöõÆ® ½ÃÀå : Porter's Five Forces ºÐ¼®

Á¦7Àå ¾È¸é ÀÓÇöõÆ® ½ÃÀå Æò°¡

  • Á¦Ç° À¯Çüº°
    • ÅΡ¤ÇÏ¾Ç ÀÓÇöõÆ®
    • ±¤´ë°ñ ¹× ±¤°ñÇÏ ÀÓÇöõÆ®
    • ÄÚ ÀÓÇöõÆ®
    • ÁÖÀÔÇü ÀÓÇöõÆ®
    • ±âŸ
  • ¼ÒÀ纰
    • ±Ý¼Ó
    • ½Ç¸®ÄÜ
    • PTFE
    • Æú¸®¿¡Æ¿·»
  • ¿ëµµº°
    • ÅÎÀÇ Áõ°­
    • ±¤´ë»À ¼ö¼ú
    • ÄÚ ¼ºÇü¼ú
  • ÃÖÁ¾ »ç¿ëÀÚº°
    • º´¿ø
    • Àü¹® Ŭ¸®´Ð
  • Áö¿ªº°
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±âŸ Áö¿ª

Á¦8Àå ¾È¸é ÀÓÇöõÆ® ½ÃÀå : ±â¾÷?Á¦Ç° ÇÁ·ÎÆÄÀÏ

  • Medartis AG
  • Eurosurgical Ltd.
  • AbbVie Inc.
  • Guangzhou Wanhe Plastic Materials Co., Ltd.
  • Sebbin
  • Hanson Medical Inc.
  • POLYTECH Health & Aesthetics GmbH
  • SurgiSil
  • Implantech
  • Surgiform Technologies LLC
  • Xilloc Medical Int BV
  • Ortho Baltic
  • Stryker
  • GALDERMA
  • Suneva Medical

Á¦9Àå KOLÀÇ °ßÇØ

Á¦10Àå ÇÁ·ÎÁ§Æ® Á¢±Ù¹ý

Á¦11Àå DelveInsight Á¤º¸

Á¦12Àå ¸éÃ¥»çÇ× ¹× ¹®ÀÇ

JHS 25.01.09

Facial Implants Market by Product Type (Chin & Mandibular Implants, Malar & Submalar Implants, Nasal Implants, Injectable Implants, and Others), Material (Metals, Silicone, ePTFE, Polyethylene, and Others), Application (Chin Augmentation, Cheek Bone Surgery, Rhinoplasty, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of acute & chronic disorders and the rising product developmental activities across the globe

The facial implants market was valued at USD 2.56 billion in 2023, growing at a CAGR of 8.02% during the forecast period from 2024 to 2030 to reach USD 4.06 billion by 2030. The facial implants market is experiencing significant growth due to the increasing instances of acute & chronic disorders including dental disorders, rising product developmental activities, growing preference for minimally invasive procedures, and availability of a wide variety of facial implants that are acting as major factors contributing to the overall growth of the facial implants market during the forecast period from 2024 to 2030.

Facial Implants Market Dynamics:

According to recent estimates from the World Health Organization (WHO), Global Oral Health Status Report (2022), oral illnesses afflict around 3.5 billion people globally, with middle-income nations accounting for three out of every four cases. The source further highlighted that 514 million children worldwide suffered from primary tooth caries, whereas an estimated 2 billion adults worldwide suffered from caries of permanent teeth annually on average.

Additionally, WHO (2023), stated that more than 1 billion adults, about 19% of the global population, are affected by severe periodontal diseases. The chief risk factor for this disease is the use of tobacco. Facial implants offer minimally invasive, precise treatments for tooth caries removal and periodontal care, making laser interventions a growing necessity for efficient, patient-friendly care and thereby bolstering the market for facial implants.

Various product developmental activities by key market players will further boost the market for same. For instance, in September 2024, Allergan Aesthetics launched BOTOX(R) Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China.

Hence, the interplay of all the above-mentioned factors is expected to drive the overall facial implants market during the given forecast period from 2024 to 2030.

However, potential risks associated with facial implants, high cost associated with facial augmentation procedures, and others may restrict the market growth for the facial implants market.

Facial Implants Market Segment Analysis:

Facial Implants Market by Product Type (Chin & Mandibular Implants, Malar & Submalar Implants, Nasal Implants, Injectable Implants, and Others), Material (Metals, Silicone, ePTFE, Polyethylene, and Others), Application (Chin Augmentation, Cheek Bone Surgery, Rhinoplasty, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the facial implants market, the chin & mandibular implant is anticipated to hold a significant market share in 2023. This is because of the rising cases of oral cancer among the population across the globe. In oral cancer when the tumor is very close or attached to the bone, mandibular resection is performed. Mandibular resection is most common for mouth cancers that begin in the lower gums or the sublingual space. For instance, according to the Global Cancer Observatory 2024, it projected that approximately 600k new cases of oral cancer will be registered by 2045. Thus, the rising oral cancer cases are likely to increase segment growth.

In addition to the above factors, the incorporation of advanced technology in the product portfolio is also one of the key factors contributing to the market growth of facial implants. For instance, in September 2021, 3D Anatomical Construction Laboratory (LARA 3D), a provincial research institute was issued Health Canada approval for its 3D printed Specifit 3D mandibular plate.

Therefore, the widespread uses and various advantages of chin & mandibular implants that enhance performance and usability will solidify the impact on the growth of the overall facial implants market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall facial implants market:

Among all the regions, North America is estimated to hold a significant revenue share in the facial implants market. This can be attributed to several factors including the rising need for aesthetic procedures, rising demand for minimally invasive treatments, and the continuous advancements in technology, that act as major factors contributing to the growth of the facial implants market in the North America region during the forecast period from 2024 to 2030.

As per data by the International Society of Aesthetic Plastic Surgery (2023), the total number of aesthetic procedures that took place in the US was 6,196,701, including both surgical and non-surgical procedures. The US was also the country with the highest number of non-surgical procedures worldwide in 2023, with 4,405,599 procedures in 2023. The source further stated that the US was the country with the highest number of aesthetic surgeons globally, with 7,750 surgeons in 2023.

In addition, as per the Global Survey (2022), in 2021, the US performed the most aesthetic procedures worldwide, accounting for 24.1% of the total procedures performed globally, with 30.4% of all non-surgical procedures and 15.5% of all surgical procedures. In 2022, the US performed over 7.4 million aesthetic procedures, which was 22% of the global number of procedures performed in 2022. The top five most popular surgical procedures in the US were liposuction, breast augmentation, eyelid surgery, rhinoplasty, and abdominoplasty, with botulinum toxin being the most common non-surgical procedure in 2022 in the US across all age groups.

As people seek both non-surgical and surgical options, interest in long-lasting facial contouring solutions, like implants, is growing. This trend supports a steady rise in facial implant demand.

Various product developmental strategies such as clearances in the region by regulatory authorities in the region play a major role in pushing forward the revenue shares of Facial Implants in the region. For example, in March 2024, the FDA approved filler for temple hollows the first and only hyaluronic acid filler with this indication.

Moreover, product launches by key market players in the region is further expected to propel the growth of the North America Facial Implants market.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the facial implants market during the forecast period from 2024 to 2030.

Facial Implants Market key players:

Some of the key market players operating in the facial implants market include Medartis AG, Eurosurgical Ltd., AbbVie Inc., Guangzhou Wanhe Plastic Materials Co., Ltd., Sebbin, Hanson Medical Inc., POLYTECH Health & Aesthetics GmbH, SurgiSil, Implantech, Surgiform Technologies LLC, Xilloc Medical Int B.V., Ortho Baltic, Stryker, GALDERMA, Suneva Medical, and others.

Recent Developmental Activities in the Facial Implants Market:

  • In August 2022, Bengaluru-based Allergan Healthcare India launched Juvederm VOLUX, an injectable implant intended to restore and create the volume of the face in India under its Business Unit of Allergan Aesthetics.
  • In February 2021, Galderma received the US Food and Drug Administration (FDA) approval Restylane(R) Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21.

Key takeaways from the Facial Implants market report study

  • Market size analysis for current facial implants market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the Facial Implants market
  • Various opportunities available for other competitors in the facial implants market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current facial implants market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for facial implants market growth in the coming future?

Target audience who can be benefited from this Facial Implants market report study

  • Facial implants providers
  • Research organizations and consulting companies
  • Facial implants-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in facial implants
  • Various end-users who want to know more about the facial implants market and the latest developments in the facial implants market

Frequently Asked Questions for the Facial Implants Market:

1. What are facial implants?

  • The facial implants are specially designed solid materials compatible with human tissues to enhance or augment the physical structure of the face. They offer a three-dimensional, permanent (when fixated) solution to volume restoration in the middle and lower face and can be serviced or removed without maximally invasive surgery.

2. What is the market for facial implants?

  • The facial implants market was valued at USD 2.56 billion in 2023, growing at a CAGR of 8.02% during the forecast period from 2024 to 2030 to reach USD 4.06 billion by 2030.

3. What are the drivers for the facial implant market?

  • The facial implants market is experiencing significant growth due to the increasing instances of acute & chronic disorders including dental disorders, rising product developmental activities, growing preference for minimally invasive procedures, and availability of a wide variety of Facial Implants that are acting as major factors contributing to the overall growth of the facial implants market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the facial implants market?

  • Some of the major market players operating in the facial implants market include Medartis AG, Eurosurgical Ltd., AbbVie Inc., Guangzhou Wanhe Plastic Materials Co., Ltd., Sebbin, Hanson Medical Inc., POLYTECH Health & Aesthetics GmbH, SurgiSil, Implantech, Surgiform Technologies LLC, Xilloc Medical Int B.V., Ortho Baltic, Stryker, GALDERMA, Suneva Medical, and others.

5. Which region has the highest share in the facial implants market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the facial implants market. This can be attributed to several factors including the rising need for aesthetic procedures, rising demand for minimally invasive treatments, and the continuous advancements in technology, which offers improved treatment features and efficiency, that are acting as major factors contributing to the growth of the facial implants market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Facial Implants Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Facial Implants Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Facial Implants Market Key Factors Analysis

  • 5.1. Facial Implants Market Drivers
    • 5.1.1. Increasing instances of acute and chronic disorders
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Growing preference of minimally invasive procedure
    • 5.1.4. Availability of wide variety facial implants
  • 5.2. Facial Implants Market Restraints and Challenges
    • 5.2.1. Potential risk associated with facial implants
    • 5.2.2. High cost associated with facial augmentation procedures
  • 5.3. Facial Implants Market Opportunities
    • 5.3.1. Growing popularity of robot-assisted laser surgeries
    • 5.3.2. Development of 3D printed facial implants

6. Facial Implants Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Facial Implants Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Chin & Mandibular Implants
    • 7.1.2. Malar & Submalar Implants
    • 7.1.3. Nasal Implants
    • 7.1.4. Injectable Implants
    • 7.1.5. Others
  • 7.2. By Material
    • 7.2.1. Metal
    • 7.2.2. Silicone
    • 7.2.3. ePTFE
    • 7.2.4. Polyethylene
    • 7.2.5. Others
  • 7.3. By Application
    • 7.3.1. Chin augmentation
    • 7.3.2. Cheek Bone surgery
    • 7.3.3. Rhinoplasty
    • 7.3.4. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Specialty Clinics
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Facial Implants Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Facial Implants Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Facial Implants Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Facial Implants Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Facial Implants Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Facial Implants Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Facial Implants market size in USD million (2021-2030)
      • 7.5.2.5. Spain Facial Implants Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Facial Implants Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.3. India Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Facial Implants Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Facial Implants Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Facial Implants Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Facial Implants Market Size in USD million (2021-2030)

8. Facial Implants Market Company and Product Profiles

  • 8.1. Medartis AG
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Eurosurgical Ltd.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. AbbVie Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Guangzhou Wanhe Plastic Materials Co., Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Sebbin
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Hanson Medical Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. POLYTECH Health & Aesthetics GmbH
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. SurgiSil
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Implantech
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Surgiform Technologies LLC
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Xilloc Medical Int B.V.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Ortho Baltic
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Stryker
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. GALDERMA
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Suneva Medical
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦